NSPR - InspireMD Corp Price Chart

InspireMD, Inc. (NSPR) develops specialized CGuard stents, the success of which depends on physician adoption and US regulatory approval. The company's price evolution on GURU.Markets reflects the dynamics of an asset with a value of 0.81. Revenues are based on insurance reimbursements and the reach of distribution networks. The business is currently focusing on organic growth and partnerships with major suppliers, having temporarily stepped away from mergers.

Quote Chart: InspireMD, Inc. (NSPR) for 07/04/2022 - 11/12/2026

Analytical breakdowns and data insights for company InspireMD Inc (NSPR)

- stock value and consensus price forecast:

Price Chart InspireMD, Inc.|NSPR - Broker Consensus Forecast

- market capitalization statistics:

Market Value InspireMD Inc|NSPR - Company Buyout Price

- balance sheet equity data:

Net Assets per Single Share InspireMD|NSPR - Net Asset Value|Market Value to Book Value Ratio inspiremd.com|NSPR - Aggregate Asset Value

- debt and liquidity details:

- company profitability and valuation multiples indicators:

NSPR - Net Financial Result|Projected Future Earnings InspireMD, Inc.|NSPR - P/E Multiple|Future Price to Earnings InspireMD|NSPR - Price/Earnings to Growth Ratio|EV/EBITDA Multiple InspireMD Inc|NSPR - Operating income before deduction of amortization|Net earnings per share for the last 12 months InspireMD|NSPR - Earnings per one share for the last 12 months|Quarterly EPS earnings growth inspiremd.com|NSPR - Earnings per share growth rate in current year|Earnings growth forecast for next year InspireMD, Inc.

Fundamental company valuation:InspireMD, Inc.

The price reflects the current market value of the equity stake in InspireMD, Inc. (NSPR), instantaneously aggregating all publicly available information regarding the business's fundamental condition. By analyzing the price chart, an investor assesses the market consensus on the company's prospects, where price stability is supported by the high loyalty of a unique engineering team that develops life-saving cardiovascular stents.

Competitors of InspireMD, Inc. (NSPR)